Learn about Yonker
Yonker founded in 2005 and we are a world-renowned professional medical equipment manufacture integrating R&D, production, sales and service. Now Yonker has seven subsidiaries.The products in3 categories cover more than 20 series include oximeters, patient monitors, ECG, syringe pumps, blood pressure monitors, oxygen concentrator, nebulizers etc., which are exported to more than 140 countries and regions.
Yonker has two R&D centers in Shenzhen and Xuzhou with a R&D team of about 100 person. At present we have nearly 200 patents and authorized trademarks. Yonker also has three production bases cover an area of 40000 square meters equipped with independent laboratories, testing centers, professional intelligent SMT production lines, dust-free workshops, precision mold processing and injection molding factories, forming a complete and cost-controllable production and quality control system. The output is nearly 12 million units to meet the customized needs of global customers.
View MoreFounded
Production Base
Export Area
Certificate
Over 17 Years+ Experience
More than 96 after sales department in Asia, Europe, South America and Africa.
Production more than 12 millions units products per year; Distribution over 140 countries and regions.
1. R&d team:
Yonker has two R&D centers in Shenzhen and Xuzhou, to meet the independent research and development and OEM customized services.
2. Technical and after-sales support
online (24-hour online customer service) + offline (Asia, Europe, South America, Africa localization service team), special dealers and OEM after-sales service team to provide perfect fault solutions and product technical guidance and training.
3. Price advantage
Yonker has the full process production capacity of mold opening, injection molding and production, with strong cost control ability and more price advantage.
View more
Learn the company's development history
Latest informations about Yonker
In recent years, the development of ultrasound medical devices has made...
...
In November 2024, our company suc...